HCA Healthcare stock heads into the October 27 earnings call

Published on 10/06/2026 at 17:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HCA Healthcare stock was last at USD 436.18 on October 6, 2026, while the next earnings call is set for October 27. Q2 revenue rose 8.7 percent to USD 20.23 billion.

Bauhaus-Grafikposter mit geometrischen Formen, HEALTHCARE-Schriftzug und NYSE-Kürzel in Primärfarben — HCA Healthcare US40412C1018 Bauhaus Poster mit geometrischen Formen und HEALTHCARE Sektortext im NYSE Design Stil, Illustration mit AI erstellt.

HCA Healthcare stock was last at USD 436.18 on the NYSE on October 6, 2026, up 0.29 percent at 11:27 a.m. ET. The next scheduled earnings call on October 27 gives investors a near-term test of admissions, reimbursement and margin trends.

October 27 sets the next checkpoint

HCA Healthcare scheduled its third-quarter 2026 earnings conference call for October 27, 2026, at 10:00 a.m. ET. That date puts the next update on operating volume and payer mix ahead of the company's full-year outlook.

The stock's intraday range was USD 430.00 to USD 436.75, with volume at 217,478 shares by 11:27 a.m. ET. Its USD 94.4 billion market capitalization places the company among the largest publicly traded hospital operators in the United States.

Quarterly growth meets a margin test

In the second quarter of 2026, HCA reported revenue of USD 20.23 billion, up 8.7 percent from the prior-year quarter, according to MarketBeat on October 5, 2026. Earnings per share reached USD 7.59 versus USD 6.84 a year earlier, while the company exceeded the USD 7.56 consensus estimate.

The revenue result also topped the USD 19.76 billion estimate cited by MarketBeat. For the October report, the key issue is whether volume growth can continue to offset payer-mix pressure and labor costs.

Analyst targets stay above the quote

On October 6, 2026, Investing.com reported that Cantor Fitzgerald reiterated an Overweight rating and a USD 525.00 price target. The target lies 20.4 percent above the USD 436.18 NYSE price, with the firm pointing to stable labor conditions and projected second-half admissions growth of 1.9 percent.

MarketBeat reported a Moderate Buy consensus based on 24 analysts, including 15 Buy, eight Hold and one Sell rating, with an average target of USD 463.70. That average target lies 6.3 percent above the October 6 price, leaving the earnings call as the next concrete test of whether the consensus can hold.

HCA Healthcare stock remains below its yearly high

HCA Healthcare stock was last at USD 436.18 on the NYSE on October 6, 2026, with a 52-week range of USD 353.99 to USD 556.52. The quote is 21.6 percent below the yearly high, while the current session's 0.29 percent gain keeps the immediate signal neutral rather than directional.